Sysmex Corporation (SSMXY) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Instruments & Supplies industria. La empresa tiene su sede en Kobe, Japan. El CEO actual es Hisashi Ietsugu.
SSMXY tiene fecha de IPO 2011-10-17, 10,042 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $5.5B.
Sysmex Corporation is a Japanese diagnostic instrument manufacturer headquartered in Kobe that develops, manufactures, and sells hematology analyzers, immunochemistry systems, flow cytometers, and related reagents and software globally. The company's product portfolio includes white blood cell differentiation instruments, urine analysis systems, infectious disease and tumor marker assays, cancer diagnostic systems, and digital medicine platforms, serving hospitals, research institutions, and medical centers across approximately 190 countries. Beyond diagnostic instruments, Sysmex provides laboratory information system software, facility management services, nucleic acid analogs, IT solutions, and medical robotics, with a strategic alliance with QIAGEN for cancer companion diagnostics development. Founded in 1968, the company has established itself as a comprehensive in vitro diagnostics provider serving both public and private healthcare institutions worldwide.
